about
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Solid-nanoemulsion preconcentrate for oral delivery of paclitaxel: formulation design, biodistribution, and γ scintigraphy imaging.Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.Nanostructured Lipid Carriers: A Novel Platform for Chemotherapeutics.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress.Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.Application of advanced oxidation processes and toxicity assessment of transformation productsNanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeuticsEpidermal growth factor receptor based active targeting: a paradigm shift towards advance tumor therapyPI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challengesExtrusion-Based 3D Printing for Pharmaceuticals: Contemporary Research and ApplicationsOleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome3D Printing Technology in Pharmaceutical Manufacturing and Drug Delivery ApplicationTopical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization
P50
Q28073956-AADF9358-0A62-487F-AB78-B5E13A49A62DQ33999835-BF2D869B-BC84-4EE9-9C22-07249E7D921FQ36019637-73DE0903-0BC0-4BD3-8A6D-21C93C1196F2Q38567910-7F86468E-54D0-4151-95C1-AEADE6002458Q38686370-2BF9E625-1AD0-430E-A8C1-2A4FF1B401A1Q39102459-FA7357C2-285E-4C36-8951-4CBF0089D3D5Q44089787-BD700A66-8345-4E51-BA91-84659AC31741Q49335000-8D19CC35-72E3-4BE4-8960-67788D864867Q51820933-A1237235-9AC0-4130-8A8A-F4D9216EF092Q57129323-27CE73F0-7C03-4858-8D47-37A549FF7708Q88827305-5F7C08B3-92E1-486B-9C24-A1662FAEF5CDQ89504870-B53B83B9-DAB6-4B91-82AF-BE0CA1FE1E52Q90105163-91C1CE3C-7350-4CF9-87C5-4E785ABFCFFEQ91017422-3143CBA6-3616-406F-805C-E15D17957571Q91351815-D318DE72-46CC-4540-9BB0-78CC3DC483FFQ92963988-D2D15442-99E9-4771-BC1E-B22DC6B83AE4Q93388325-2FB8FF01-8A93-4A90-BD60-54965DB2A927
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Javed Ahmad
@en
Javed Ahmad
@nl
type
label
Javed Ahmad
@en
Javed Ahmad
@nl
prefLabel
Javed Ahmad
@en
Javed Ahmad
@nl
P31
P496
0000-0002-7025-751X